Cx Precision Medicine
Cx Precision Medicine is a healthcare company focused on revolutionizing geriatric medicine through precision diagnostics for neurodegenerative diseases. Their flagship product, NeuroFirst™ Memory, is a blood test designed for people over 60 to help primary care physicians accurately rule out Alzheimer's Dementia and differentiate memory complaints, enabling earlier and targeted treatments. The technology combines proteomics and artificial intelligence, analyzing numerous blood proteins with sophisticated algorithms trained on thousands of samples. The company holds 13 issued patents and licenses technology from the University of North Texas Health Science Center. Their approach shifts from one-size-fits-all to personalized medicine based on genetics, environment, and lifestyle, aiming to improve outcomes and reduce costs. They are also developing NeuroFirst™ Parkinson's test to aid early Parkinson's Disease detection.
Cx Precision Medicine
Cx Precision Medicine is a healthcare company focused on revolutionizing geriatric medicine through precision diagnostics for neurodegenerative diseases. Their flagship product, NeuroFirst™ Memory, is a blood test designed for people over 60 to help primary care physicians accurately rule out Alzheimer's Dementia and differentiate memory complaints, enabling earlier and targeted treatments. The technology combines proteomics and artificial intelligence, analyzing numerous blood proteins with sophisticated algorithms trained on thousands of samples. The company holds 13 issued patents and licenses technology from the University of North Texas Health Science Center. Their approach shifts from one-size-fits-all to personalized medicine based on genetics, environment, and lifestyle, aiming to improve outcomes and reduce costs. They are also developing NeuroFirst™ Parkinson's test to aid early Parkinson's Disease detection.